Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c

Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q2 EPS of ($0.53), $0.04 better than the analyst estimate of ($0.57).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
• Boeing wins $13.4 billion contract modification from US military